Showing results (1101-1110 of 1,291) with videos related to

Sort By:
Pageof 130
Blood Advances|December 10, 2024
Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE studyVania Hungria, Rafael Gaiolla, Kenny Galvez, et al.
The Lancet. Oncology|December 15, 2023
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 studyEnrique Grande, José Á Arranz, Maria De Santis, et al.
The Lancet. Oncology|December 15, 2023
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 studyAristotelis Bamias, Ian D Davis, Matthew D Galsky, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 3, 2025
Recent Antiretroviral Therapy Initiation Is Associated With Increased Mortality Risk in HIV-associated Cryptococcal Meningitis: An Analysis of Clinical Trial Data From AfricaMelanie Moyo, David S Lawrence, James Jafali, et al.
Oncoimmunology|March 28, 2017
PD-L1, Galectin-9 and CD8<sup>+</sup> tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinomaKostandinos Sideras, Katharina Biermann, Joanne Verheij, et al.
Physical Review Letters|March 23, 2002
Suppression of soft nuclear bremsstrahlung in proton-nucleus collisionsM J van Goethem, L Aphecetche, J C S Bacelar, et al.
Leukemia & Lymphoma|July 7, 2020
Primary refractory multiple myeloma: a real-world experience with 85 casesArtur Jurczyszyn, Anna Waszczuk-Gajda, Jorge J Castillo, et al.
JAMA Network Open|January 13, 2025
Androgen Receptor Pathway Inhibitor Therapy for Advanced Prostate Cancer: Secondary Analysis of a Randomized Clinical TrialDiogo Assed Bastos, Andrey Soares, Fabio Augusto Barros Schutz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2020
Cerebrospinal Fluid Early Fungicidal Activity as a Surrogate Endpoint for Cryptococcal Meningitis Survival in Clinical TrialsMatthew F Pullen, Katherine Huppler Hullsiek, Joshua Rhein, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 16, 2022
Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United StatesMaria Karlsson, Joseph D Lutgring, Uzma Ansari, et al.
Pageof 130